BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

576 related articles for article (PubMed ID: 10544747)

  • 1. [Treatment of thrombotic microangiopathies].
    Debourdeau P; Zammit C; Souleau B; Védrine L; Farge-Bancel D
    Ann Med Interne (Paris); 1999 Sep; 150(5):374-87. PubMed ID: 10544747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of thrombocytopenic thrombotic purpura].
    Corte Buelga JR; Rodríguez Vicente P; García Gala JM; Alonso García AM; Martínez Revuelta E
    Sangre (Barc); 1997 Feb; 42(1):53-61. PubMed ID: 9229804
    [No Abstract]   [Full Text] [Related]  

  • 3. Pathophysiology and management of thrombotic microangiopathies.
    Ruggenenti P; Remuzzi G
    J Nephrol; 1998; 11(6):300-10. PubMed ID: 10048496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Microangiopathic hemolytic anemias. Clinical pattern, therapy and clinical course in 14 patients with thrombotic thrombocytopenic purpura and hemolytic uremic syndrome].
    Krause M; Fehr J; Gmür J; Keusch G; Frick P; Oelz O
    Schweiz Med Wochenschr; 1986 Nov; 116(48):1666-74. PubMed ID: 3798063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombotic thrombocytopenic purpura. II. Principles of therapy and guidelines for management.
    Sills RH
    Am J Pediatr Hematol Oncol; 1984; 6(4):431-9. PubMed ID: 6398631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients.
    Bell WR; Braine HG; Ness PM; Kickler TS
    N Engl J Med; 1991 Aug; 325(6):398-403. PubMed ID: 2062331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma manipulation in hemolytic uremic syndrome and thrombotic thrombocytopenic purpura.
    Remuzzi G; Ruggenenti P
    Ann Med Interne (Paris); 1992; 143 Suppl 1():19-26. PubMed ID: 1300882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombotic thrombocytopenic purpura and related disorders.
    Ruggenenti P; Remuzzi G
    Hematol Oncol Clin North Am; 1990 Feb; 4(1):219-41. PubMed ID: 2107174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological characteristics and outcome of Chinese patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: a 9-year retrospective study.
    Zhang W; Shi H; Ren H; Shen PY; Pan XX; Li X; Chen YX; Xu YW; Chen XN; Zhu P; Chen N
    Nephron Clin Pract; 2009; 112(3):c177-83. PubMed ID: 19439988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous intravenous infusion of dipyridamole as adjunctive therapy in the treatment of thrombotic thrombocytopenic purpura.
    Quintini G; Barbera V; Iannitto E; Spadola V; Fadda R; Greco G; Mazzola G; Mariani G
    Transfus Apher Sci; 2003 Oct; 29(2):141-5. PubMed ID: 12941352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Thrombotic microangiopathy in adults].
    Barrientos GJ; Michelangelo H
    Medicina (B Aires); 2006; 66(4):289-95. PubMed ID: 16977962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: pathophysiology and management.
    Myers L
    Nephrol Nurs J; 2002 Apr; 29(2):171-80; quiz 181-2. PubMed ID: 11997952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment outcomes in patients with adult thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.
    Hayward CP; Sutton DM; Carter WH; Campbell ED; Scott JG; Francombe WH; Shumak KH; Baker MA
    Arch Intern Med; 1994 May; 154(9):982-7. PubMed ID: 8179455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathophysiology and treatment of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS).
    Kakishita E
    Int J Hematol; 2000 Jun; 71(4):320-7. PubMed ID: 10905050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombotic microangiopathy: current knowledge and outcomes with plasma exchange.
    Clark WF
    Semin Dial; 2012; 25(2):214-9. PubMed ID: 22309967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Re-examination of 30-day survival and relapse rates in patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.
    Bittencourt CE; Ha JP; Maitta RW
    PLoS One; 2015; 10(5):e0127744. PubMed ID: 26000799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of response and relapse in a cohort of adults with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: a single-institution experience.
    Tuncer HH; Oster RA; Huang ST; Marques MB
    Transfusion; 2007 Jan; 47(1):107-14. PubMed ID: 17207238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombotic thrombocytopenia purpura (TTP) and other thrombotic microangiopathies.
    Moake J
    Best Pract Res Clin Haematol; 2009 Dec; 22(4):567-76. PubMed ID: 19959109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The renal manifestations and outcome of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in adults.
    Conlon PJ; Howell DN; Macik G; Kovalik EC; Smith SR
    Nephrol Dial Transplant; 1995; 10(7):1189-93. PubMed ID: 7478122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemolytic uremic syndrome/thrombotic thrombocytopenic purpura (HUS/TTP) complicating adult Still's disease: remission induced with intravenous immunoglobulin G.
    Diamond JR
    J Nephrol; 1997; 10(5):253-7. PubMed ID: 9364316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.